Actively Recruiting
Observational Study Tracking Short-Term Changes in Geographic Atrophy Due to Age-Related Macular Degeneration in Adults 55 and Older
Led by Complement Therapeutics · Updated on 2026-08-06
75
Participants Needed
14
Research Sites
13 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are conducting an observational study to understand the short-term progression of geographic atrophy GA caused by age-related macular degeneration AMD in adults aged 55 years and older. The study aims to identify participants with progressive GA to measure structural and functional changes and explore whether these changes relate to genetic or lifestyle factors. This multi-center research provides insights into disease progression without introducing any treatment interventions. Participants with bilateral GA secondary to AMD will be observed over time. The study involves assessments at baseline, month 3, and month 6 to measure the progression of GA using imaging techniques such as fundus autofluorescence FAF and optical coherence tomography OCT. Researchers will quantify GA lesion size and evaluate visual function parameters, including best-corrected visual acuity BCVA and retinal sensitivity using microperimetry. During the study, participants will attend visits for eye examinations and imaging at specified time points to monitor GA progression. The research team will use these assessments to analyze short-term changes in GA and explore correlations with genetic and lifestyle factors. The total participation duration is approximately six months, during which safety and vision measures will be carefully monitored.
CONDITIONS
Brief Title
A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
Research Team
M
Muhammad Ali Memon
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here